Trafalgar International (OTCMKTS:GCAN) Shares Down 26.6% – Should You Sell?

Trafalgar International (OTCMKTS:GCAN – Get Free Report)’s stock price was down 26.6% during mid-day trading on Tuesday. The company traded as low as $0.80 and last traded at $0.80. 1,617 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 8,036 shares. The stock had previously closed at $1.09.

Trafalgar International Price Performance

The firm has a 50 day moving average price of $1.40 and a 200-day moving average price of $1.10.

About Trafalgar International

(Get Free Report)

The Greater Cannabis Company, Inc, a biopharmaceutical company, focuses on the development and commercialization of technology for transmucosal delivery of legal medical or recreational cannabis and cannabinoids. It intends to commercialize the technology by sublicensing or partnering with licensed producers, distributors, processors, consumer product, and pharmaceutical companies. The company was founded in 2014 and is based in Baltimore, Maryland.

Featured Articles

Receive News & Ratings for Trafalgar International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trafalgar International and related companies with MarketBeat.com's FREE daily email newsletter.